AMSBIO has announced a new portfolio of Rabbit Monoclonal Antibodies for Immunohistochemistry

AMSBIO has announced a new portfolio of rabbit monoclonal and polyclonal antibodies for Immunohistochemistry (IHC) applications. A rabbit custom antibody service is also available. Antibodies produced by rabbits are reported to often provide superior antigen recognition, greater specificity, and better consistency than those offered by mice. Rabbit antibodies often can recognise certain antigens and epitopes [...]

Biotage Partners with John Morris Scientific for Distribution in Australia and New Zealand

Uppsala, Sweden -- Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, announced a partnership with John Morris Scientific Pty Ltd (JMS), a leading distributor in Australia and New Zealand. The addition of JMS better positions the company to take advantage of the increased demand for Biotage products in the region. [...]

Arrayit Wins Landmark DNA Testing Patent in Israel

New Technology Promises Economies of Scale in Healthcare SUNNYVALE, Calif. -- Arrayit Corporation (OTC Bulletin Board: ARYC), a life sciences and healthcare technology leader, announced today that the Company has received patent protection in the State of Israel for its proprietary Variation Identification Platform™ (VIP™) DNA testing technology. The Israeli patent extends Arrayit's current patent [...]

Optibrium Unveils StarDrop 4.3

Delivering Enhanced Features to Guide Decisions for Drug Optimisation CAMBRIDGE, UK -- Optibrium, a provider of software solutions for drug discovery, today launches StarDrop 4.3. The intuitive software offers advantages over traditional predictive modeling platforms as it specifically helps users to identify chemistries with a high chance of success and focus expensive in-house resources. Used [...]

New Peptide Array Applications from GWC Technologies

GWC Technologies is pleased to announce development of new peptide array applications for direct analysis of antibodies in unpurified serum and egg yolk, using the SPRimager®II label-free array platform. Label-free peptide array analysis delivers multiple benefits: - Peptides make attractive affinity probes due to their robustness and specificity - The ability to interrogate targets in [...]

Sequenom Announces Launch of SensiGene Fetal RHD Genotyping Test

First Commercial Test using SEQureDx Technology for Determining Rhesus D Incompatibility SAN DIEGO -- Sequenom, Inc. (Nasdaq: SQNM) today announced the launch of the SensiGene™ Fetal RHD Genotyping test by Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM). This is the company's first laboratory developed test powered by its SEQureDx™ [...]

Optibrium Unveils StarDrop 4.3

Delivering Enhanced Features to Guide Decisions for Drug Optimisation CAMBRIDGE, UK -- Optibrium, a provider of software solutions for drug discovery, today launches StarDrop 4.3. The intuitive software offers advantages over traditional predictive modeling platforms as it specifically helps users to identify chemistries with a high chance of success and focus expensive in-house resources. Used [...]

Thermo Fisher Scientific Ships 2000th iCAP 6000 Series ICP Emission Spectrometer

CAMBRIDGE, UK -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Bormioli Rocco, a producer of glass and plastic pharmaceutical packaging, glass containers for perfumery and foodstuffs and glass tableware, has purchased and deployed the 2000th Thermo Scientific iCAP 6000 Series inductively coupled plasma (ICP) emission spectrometer. The company relies [...]

QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients

MANCHESTER, England & NEW YORK--Pfizer Inc. (NYSE: PFE) and DxS (a wholly owned subsidiary of QIAGEN N.V.) (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM). Financial [...]

/C O R R E C T I O N — Arrayit Corporation/

In the news release, Arrayit Wins Landmark DNA Testing Patent in Israel, issued 04-Feb-2010 by Arrayit Corporation over PR Newswire, we are advised by the company that Patent Number 153848 in the first sentence of the second paragraph should link to the following website: https://www.ilpatsearch.justice.gov.il/UI/MainPage.aspx. The complete, corrected release follows: Arrayit Wins Landmark DNA Testing [...]

Access IBO on Knowledge Center